NCT05763069

Brief Summary

High-risk pregnancies often require long-term hospitalization or outpatient maternal and/or fetal monitoring, placing a burden on patients, hospital resources and society. The demand for intensified pregnancy surveillance and interventions is increasing, due to the increased prevalence of risk factors like obesity and advanced maternal age, as well as altered guidelines resulting in increasing labor induction rates.The main aims of the HOME study (Home monitoring of pregnancies at risk) are to assess if home monitoring of selected high-risk pregnancies for maternal and fetal wellbeing is feasible, safe (in a clinical trial), cost-efficient, and simultaneously empowers the users.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
174mo left

Started Nov 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Nov 2022Sep 2040

Study Start

First participant enrolled

November 21, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 10, 2023

Completed
12.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2035

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2040

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

12.8 years

First QC Date

February 28, 2023

Last Update Submit

February 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of Home monitoring of high-risk pregnancies

    Development of secure data transfer systems from home to electronic patient records at the hospital

    2022-2035

Secondary Outcomes (4)

  • User acceptability of home monitoring

    2022-2035

  • Clinical safety of home monitoring

    2022-2035

  • Health economics of home monitoring

    2022-2035

  • Placenta-associated biomarkers: improving CTG prediction of adverse outcomes?

    2023-2035

Interventions

Offer women with pregnancies at risk home surveillance instaed of more frequent hospital out-patient visits and/or hospitalisation: cardiotocographia (CTG), patient measurements of CRP, temperature, blood pressure, and clinical signs of infection or severe forms of preeclampsia.

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women identified with the at-risk pregnancies described above, attending Oslo University Hospital's Department of Obstetrics (some controls will also be recruited at another South-Eastern Norway Dept of Obstetrics, at Drammen hospital).

You may qualify if:

  • Preeclampsia
  • Gestational Hypertension
  • Premature Preterm Rupture of Membranes
  • High Risk Pregnancy
  • Previous adverse obstetric outcomes

You may not qualify if:

  • Multiples (twins, triplets etc)
  • Patient or fetus in immediate need for delivery
  • Not understanding Norwegian
  • Not mastering the technological aspects of home monitoring
  • Long travel distance to Obstetric Department

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0424, Norway

Location

Related Publications (1)

  • Waldum AH, Pay ASD, Aasbo G, Mishra VK, Sugulle M, Staff AC. The HOME (home monitoring of high-risk pregnancies) study: a study protocol for an observational study of a telemedicine-assisted follow-up at home vs. hospitalization. Front Glob Womens Health. 2025 Jul 14;6:1599153. doi: 10.3389/fgwh.2025.1599153. eCollection 2025.

MeSH Terms

Conditions

ToxemiaPre-Eclampsia

Condition Hierarchy (Ancestors)

InfectionsHypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Anne Cathrine Staff, MD, PhD

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Head of research, MD; PhD

Study Record Dates

First Submitted

February 28, 2023

First Posted

March 10, 2023

Study Start

November 21, 2022

Primary Completion (Estimated)

September 1, 2035

Study Completion (Estimated)

September 1, 2040

Last Updated

February 18, 2026

Record last verified: 2026-02

Locations